Lung Cancer Journal

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Lung Cancer Journal
Dec 30, 2024, 12:03 | Science
Misty Dawn Shields: Rare lung cancers have a paucity of info and they aren’t in first place
Misty Dawn Shields, Translational Thoracic Oncologist at The Shields Lab, shared a post on X about…
Dec 27, 2024, 17:00 | Science
Corinne Faivre-Finn: An International EORTC Survey on Stage III NSCLC resectability
Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology at the University of Manchester, posted on X…
Dec 2, 2024, 10:22 | Blog
Tejas Patil: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in non-small cell lung cancer
Tejas Patil, Thoracic oncologist at University of Colorado Cancer Center, posted on X about recent…
Nov 30, 2024, 19:38 | Insight
Stephen V Liu: Is there value in continuing osimertinib beyond progression?
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a recent article by Tejas…
Nov 14, 2024, 15:41 | Insight
Pasquale Pisapia: The relevance of the reference range for EGFR testing in non-small cell lung cancer patients
Pasquale Pisapia, Associate Editor section "Oncology" at Heliyon, shared a post on X: “Thrilled to…
Oct 16, 2024, 18:00 | Insight
Stephen V Liu: Is immunotherapy effective for HER2 mutant NSCLC?
Stephen V Liu shared on X a recent paper by Yuki Kato et al. titled…
Oct 7, 2024, 15:38 | Insight
Stephen V Liu: Afatinib and Bevacizumab in EGFR NSCLC
Stephen V Liu posted the following on X: “Phase II ABCD study of afatinib and…
Oct 2, 2024, 14:41 | Insight
Stephen Liu: Phase Ib study of naporafenib with rineterkib or trametinib in NSCLC
Stephen Liu shared a post on X about a recent paper by David Planchard et…
Sep 10, 2024, 11:17 | Insight
Jennifer Marks: Our MET-working paper in collaboration with Caris Life Sciences
Jennifer Marks shared a post on X: “Our MET-working paper in collaboration with Caris Life…
Aug 14, 2024, 07:04 | Insight
ES-SCLC 5-year survival outcomes inIMpower133 and IMbrella study
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X, about recent paper…
Aug 14, 2024, 02:11 | Insight
Felipe Couñago: Analyzing diagnostic and treatment wait times for lung cancer Patients
Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X about a…
Aug 3, 2024, 08:51 | Blog
Filippo Gallina: PD-L1 testing in the context of neoadjuvant chemo-immunotherapy
Filippo Gallina, Research Fellow at McGill University Health, shared his recent article on X: "Happy…
Jul 29, 2024, 21:28 | Insight
RWO with chemotherapy for patients who progress after PACIFIC regimen
Stephen Liu shared a post on X about a recent paper by Hayato Kawachi et al.…
Jul 18, 2024, 11:08 | Blog
Stephen V Liu: Retrospective study looks at immunotherapy in patients with NSCLC and autoimmune condition
Stephen V Liu shared on X: "Retrospective NEJ047 study looks at immunotherapy in patients with NSCLC…
Jul 12, 2024, 14:18 | Blog
Updated review on targeting KRAS in NSCLC
Stephen V Liu shared on X: "Updated review on targeting KRAS in NSCLC available in…
Jul 12, 2024, 11:24 | Insight
What comes after sotorasib and adagrasib?
Aakash Desai, Thoracic/Phase 1 Oncologist at UAB O'Neal Comprehensive Cancer Center, shared a post on…
Jun 21, 2024, 09:39 | Insight
Stephanie Saw: Real-world evidence of adding pemetrexed-platinum chemotherapy upon osimertinib progression
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared on X/Twitter: "Just out in…
Jun 19, 2024, 12:19 | Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Jun 13, 2024, 13:34 | Insight
Stephen Liu: Report on brain metastases in patients with KRAS NSCLC
Stephen Liu shared on X/Twitter: "Report on brain metastases in patients with KRAS NSCLC in phase…
Jun 3, 2024, 23:19 | Blog
Indu Voruganti Maddali: Our manuscript 'Optimal management of radiation pneumonitis' is now in Lung Cancer Journal
Indu Voruganti Maddali, Radiation Oncologist at University of Toronto, shared a post on X: "Our manuscript…
Apr 13, 2024, 12:35 | Opinion
Stephen V Liu: Some guidance on the management of adverse events with sotorasib in KRAS G12C NSCLC Lung Cancer Journal
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared a post…
Apr 11, 2024, 17:17 | Insight
Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management
Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices…
All: 22 Posts: 1 - 100
Special Coverage